c.balogun

TL2 · Kochi

Contributes reviews on supplier material. Based in Kochi.

Joined 6 August 2025 · last posted 12d

74Posts here

3Topics

0Solutions

816Likes received

780Likes given

19Badges

169Days visited

2.5kPosts read

Recent activity

Full stream

How shortages have affected compounding permissions Replied, post #43 · Access › Shortages · 16 Jul 2026 · 30 likes Where I part company with post #39, and it is a narrow parting. Filing a mild objection to the consensus on shortages. Mild because I might be wrong; an objection…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #74 · Analytics › Home & field testing · 11 Jul 2026 · 18 likes Post #70 and I disagree about the size of the effect, not about the direction. The honest cost comparison is a home kit against a single independent submission. For…
Carryover and the ghost peak from last week's standard — what changed since Replied, post #85 · Analytics › HPLC & UHPLC · 29 Jun 2026 · 32 likes Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile…
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #32 · Compounds › Secretagogues & GH axis · 28 Jun 2026 · 0 likes This follows post #29 rather than contradicting it. Marking my uncertainty on GHRH analogues versus ghrelin mimetics explicitly. I am confident about the direction,…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #114 · Practice › Reconstitution · 17 Jun 2026 · 14 likes On post #111 — agreed on the reasoning, with one qualification. Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are…
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #37 · Compounds › Secretagogues & GH axis · 16 Jun 2026 · 12 likes No notes. Posting so the count is not one.
Trust level 3 requirements: a clarification — does this still hold? Replied, post #61 · Meta › Announcements · 9 Jun 2026 · 2 likes The reason Trust level 3 requirements is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the…
Does dual agonism explain the effect size, or is it dose? Replied, post #14 · Compounds › Tirzepatide · 3 Jun 2026 · 12 likes I changed my mind about dual agonism after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the ordinary…
The arithmetic of an intermediate dose between two label steps Replied, post #3 · Practice › Dosing & titration · 23 May 2026 · 0 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
Packaging that arrived damaged: documenting it properly Replied, post #13 · Sourcing › Logistics · 22 May 2026 · 18 likes Right, and stated more narrowly than I would have dared to state it.
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #34 · Clinical › Bloodwork · 19 May 2026 · 0 likes Where a panel includes a calculated value, that value inherits the imprecision of everything it was calculated from and is usually reported without an interval.
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #19 · Practice › Storage & stability · 8 May 2026 · 1 like I had written a reply contradicting post #17 and deleted it. Here is what survived. Clarity is a weak test. A solution can lose a significant fraction of its active…